GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models ; volume:66 ; number:7 ; day:30 ; month:3 ; year:2023 ; pages:1306-1321 ; date:7.2023
Diabetologia ; 66, Heft 7 (30.3.2023), 1306-1321, 7.2023

Creator: Gorgogietas, Vyron
Rajaei, Bahareh
Heeyoung, Chae
Santacreu, Bruno J.
Marín-Cañas, Sandra
Salpea, Paraskevi
Sawatani, Toshiaki
Musuaya, Anyishai
Arroyo, María N.
Moreno-Castro, Cristina
Benabdallah, Khadija
Demarez, Celine
Toivonen, Sanna
Cosentino, Cristina
Pachera, Nathalie
Lytrivi, Maria
Cai, Ying
Carnel, Lode
Brown, Cris
Urano, Fumihiko
Marchetti, Piero
Gilon, Patrick
Eizirik, Decio L.
Cnop, Miriam
Igoillo-Esteve, Mariana

Contributor: SpringerLink (Online service)

DOI: 10.1007/s00125-023-05905-8

URN: urn:nbn:de:101:1-2023091516273266858285

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:54 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Gorgogietas, Vyron
Rajaei, Bahareh
Heeyoung, Chae
Santacreu, Bruno J.
Marín-Cañas, Sandra
Salpea, Paraskevi
Sawatani, Toshiaki
Musuaya, Anyishai
Arroyo, María N.
Moreno-Castro, Cristina
Benabdallah, Khadija
Demarez, Celine
Toivonen, Sanna
Cosentino, Cristina
Pachera, Nathalie
Lytrivi, Maria
Cai, Ying
Carnel, Lode
Brown, Cris
Urano, Fumihiko
Marchetti, Piero
Gilon, Patrick
Eizirik, Decio L.
Cnop, Miriam
Igoillo-Esteve, Mariana
SpringerLink (Online service)

Other Objects (12)

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Effects of GLP-1 receptor agonists on neurological complications of diabetes

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Effects of GLP-1 receptor agonists on neurological complications of diabetes

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Effects of GLP-1 receptor agonists on neurological complications of diabetes

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

GLP-1R agonists demonstrate potential to treat Wolfram syndrome in human preclinical models

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Effects of GLP-1 receptor agonists on neurological complications of diabetes

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Effects of GLP-1 receptor agonists on neurological complications of diabetes

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Effects of GLP-1 receptor agonists on neurological complications of diabetes

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Potential implications of long-acting GLP-1 receptor agonists for critically ill

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β ‐Klotho‐Mediated Ferroptosis Inhibition

Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

ACE2 and SARS-CoV-2 Infection: Might GLP-1 Receptor Agonists Play a Role?

Related objects

Reset password